KYORIN Pharmaceutical
4569.TSE
7.22 USD
-0.01
-0.14%
k
Overview
Last close
7.22 usd
Market cap
415.04M usd
52 week high
11.04 usd
52 week low
6.62 usd
Target price
7.01 usd
Valuation
P/E
18.9747
Forward P/E
8.547
Price/Sales
0.5211
Price/Book Value
0.4619
Enterprise Value
452.90M usd
EV/Revenue
0.563
EV/EBITDA
7.5883
Key financials
Revenue TTM
800.73M usd
Gross Profit TTM
322.00M usd
EBITDA TTM
43.22M usd
Earnings per Share
0.38 usd
Dividend
0.36 usd
Total assets
1.16B usd
Net debt
58.90M usd
About
KYORIN Pharmaceutical Co., Ltd., through its subsidiaries, researches and develops, manufactures, and sells generic drugs in Japan and internationally. The company is also involved in drug discovery and licensing activities. It also offers infectious disease-related products; over-the-counter drug; and generic drugs. The company was formerly known as KYORIN Holdings, Inc. KYORIN Pharmaceutical Co., Ltd. was founded in 1923 and is headquartered in Tokyo, Japan.
- Symbol4569.TSE
- ExchangeTSE
- IsinJP3247090008
- CountryJapan
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CEOMr. Yutaka Ogihara
- HeadquarterTokyo
- Web sitehttps://www.kyorin-pharm.co.jp
